medline.ch Gastroenterologie Oesophagus Neoplasie

	Hollow Cu(2-x)Se/PDA/IR820 Composite Nanoparticles with pH Response for Multimodal Synergistic Treatment of Esophageal Cancer. Int J Nanomedicine Ma F, Ji A, Ma B, Yang P, Li J, Liao S, Yao H, Xie X, Wang Z, Shi L, Gao S, Hou X. PMID: 42199656 [PubMed - in process]
	Angiotensin inhibitors during neoadjuvant chemotherapy improve esophageal squamous cell carcinoma outcomes. Ther Adv Med Oncol Chen M, Huang Y, Liu F, Lin C, Zhang S, Zeng T, Yu J, Zheng B, Chen C. PMID: 42199486 [PubMed]
	First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis. Medicina (Kaunas) Seyyar M, Can , Sakin A, Bayramgil A, Dülgar Kaya Ö, Sünger E, Aç, Demir T, Türkel R, Y, Özalp FR, Semiz HS, Y, Aykan MB, Turhan G, Y, Menek, Kut E, Çakmak M, Alg, , Karakayal, O, Artaç M, , Paçac, Sar, , Guliyev M, Demirci NS, Çavdar E, Elçiçek ÖF, , Bölek H, Kubilay Tolunay P, Kalem A, Yaz, Merç Çetinkaya A, Akba, Biter S, Kitapl, Özkan MK, , Majidova N, Arak H, Y, Çabuk D, Uygun K, Sezgin Göksu S, Tanr, Selçukbiricik F, Uzun M, Ökten , Mete B, Kö, Bilici A, Ku, Dizdar Ö, Yalç, Kefeli U. PMID: 42195237 [PubMed - indexed for MEDLINE]
	State-of-the-Art Mediastinal Staging in Non-Small-Cell Lung Cancer: Integration of Combined Endosonographic Techniques with Updated IASLC TNM 9th Classification. Cancers (Basel) Alkathiri O, Liberman M. PMID: 42193023 [PubMed]
	Efficacy of Spectral-Aided Visual Enhancer in Classification of Esophageal Cancer. Cancers (Basel) Koh KY, Mukundan A, Karmakar R, Atulbhai CT, Chen TH, Weng WC, Wang HC. PMID: 42192971 [PubMed]
	Artificial Intelligence in Oncology: A Comprehensive Cross-Cancer Translational Readiness Analysis Across 18 Malignancies. Cancers (Basel) Kuchana SK, Repalle UK, Alahari NV, Kondamuri M, Manduva SK, Vanguru RV, Gorle SA, Alahari SK. PMID: 42192906 [PubMed]
	A novel mucosal lymphatic vessel classification correlating with histopathology of early esophageal squamous cell carcinoma: A proposed system from China. Chin Med J (Engl) Zhang Y, Peng T, Ye L, Chen L, Yuan X, Yao M, Feng Y, Zeng X, Chen O, Gao Y, Luo Q, Zhu Y, Zhang L, Liu W, Mou Y, He L, Zhou X, Deng Q, Hu B. PMID: 42192218 [PubMed - as supplied by publisher]
	AI-driven multi-omics drug repurposing nominates AZD7762 as a multitarget inhibitor of IL22RA1 and FAM221A in esophageal squamous cell carcinoma. NPJ Precis Oncol Zhuang Z, Yu S, Peng K, Zhang P, Yu J, Lin J, Kang M. PMID: 42191940 [PubMed - as supplied by publisher]
	Endoscopy-based Deep Learning Algorithms versus Endoscopists in Early Esophageal Squamous Cell Carcinoma Detection: A Systematic Review and Meta-Analysis. Am J Gastroenterol Men X, Wang Y, Zhao Y, Zhang H, Zhang X. PMID: 42189588 [PubMed - as supplied by publisher]
	Diagnostic performance of [(18)F]Tetrafluoroborate PET versus (131)I scintigraphy in differentiated thyroid cancer: a prospective study. Eur J Nucl Med Mol Imaging Sonmezoglu K, Sahin OE, Saglam K, Karayel E, Pehlivanoglu H, Uslu-Besli L, Sayman HB. PMID: 42189228 [PubMed - as supplied by publisher]
	Association Between Regional Cardiac Radiation Dose and Magnetic Resonance Imaging Myocardial Contractility Parameters: A Prospective Pilot Study. Tomography Ibrahim EH, Klawikowski S, Puckett L, Gore E, An D, Bychowski J, Sosa A, Walls G, Bergom C. PMID: 42188711 [PubMed - indexed for MEDLINE]
	Association Between Triglyceride-Glucose Index and Risk of Cancer: A Systematic Review and Meta-Analysis. J Pers Med Fabiani R, Squadroni V, Rosignoli P. PMID: 42188369 [PubMed]
	Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study. J Gastrointest Cancer Fujimoto A, Uozumi R, Fujii H, Tamaki S, Eto T, Yamaguchi M, Maehara Y, Iihara H, Hatakeyama T, Higuchi A, Kawazoe H, Ohtani H. PMID: 42183961 [PubMed - indexed for MEDLINE]
	Sequential versus concurrent neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a randomized, controlled, open-label, phase 2 trial (HCHTOG1906). Front Immunol Zheng Y, Wu J, Zhao L, Shen Y, Liang G, Li K, Gao Q, Xing W. PMID: 42183251 [PubMed - indexed for MEDLINE]
	Development and validation of nomograms integrating electrolyte, nutritional, and inflammatory indicators to predict survival in advanced esophageal cancer undergoing immunotherapy or radioimmunotherapy. J Thorac Dis Tang S, Feng C, Liang N, Qiao L, Lu Z, Lv Y, Yang X, Hao Y, Zhang J. PMID: 42182758 [PubMed]
	Identification and validation of prognostic genes related to mitochondrial dynamics and mitochondrial autophagy in esophageal squamous cell carcinoma. J Thorac Dis Lin H, Zhuang FN, Chen WJ, Wei WW, Gao PQ, Wang PY, Wang F, Shi S. PMID: 42182752 [PubMed]
	Lesion-level comparison of primary and secondary tumors after neoadjuvant immunochemotherapy in multifocal esophageal squamous cell carcinoma: a single-center retrospective study. J Thorac Dis Liu X, Zhang G, Wang W, Li J. PMID: 42182719 [PubMed]
	Active surveillance for esophageal cancer after clinically complete response: relevant considerations of the SANO-trial. J Thorac Dis van der Wilk BJ, Wijnhoven BPL, van Lanschot JJB. PMID: 42182714 [PubMed]
	Erratum: Biofunctional study on chemoresistance in esophageal squamous carcinoma cells induced by missense mutation of NOTCH1 p.E450K. J Thorac Dis Editorial Office. PMID: 42182698 [PubMed]
	Integrating genetic and transcriptomics data to predict neoadjuvant chemoradiotherapy for patients with esophageal squamous cell carcinoma. J Thorac Dis Li T, Li H, Ye X, Hu Y. PMID: 42182675 [PubMed]

Artikel 1 - 20 / 38899

Seite 1 von 1945

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung